CSIMarket
 


Comera Life Sciences Holdings Inc   (CMRA)
Other Ticker:  
 
 

CMRA's Revenue Growth by Quarter and Year

Comera Life Sciences Holdings Inc 's Revenue results by quarter and year




CMRA Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.25 0.00 0.00
III Quarter September 0.14 0.23 0.00 0.00
II Quarter June 0.32 0.15 0.00 0.00
I Quarter March 0.39 0.00 0.00 0.00
FY   0.85 0.63 0.00 0.00



CMRA Revenue third quarter 2023 Y/Y Growth Comment
Comera Life Sciences Holdings Inc reported fall in Revenue in the third quarter 2023 by -40.73% to $ 0.14 millions, from the same quarter in 2022.
The drop in the third quarter 2023 Comera Life Sciences Holdings Inc 's Revenue compares unfavorably to the Company's average Revenue rise of 36.37%.

Looking into third quarter 2023 results within Major Pharmaceutical Preparations industry 174 other companies have achieved higher Revenue growth. While Comera Life Sciences Holdings Inc ' s Revenue drop of -40.73% ranks overall at the positon no. 3049 in the third quarter 2023.




CMRA Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September -40.73 % - - -
II Quarter June 113.33 % - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Comera Life Sciences Holdings Inc 's third quarter 2023 Revenue $ 0.14 millions CMRA's Income Statement
Comera Life Sciences Holdings Inc 's third quarter 2022 Revenue $ 0.23 millions Quarterly CMRA's Income Statement
New: More CMRA's historic Revenue Growth >>


CMRA Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 8.7 % - -
III Quarter September -57.4 % 53.33 % - -
II Quarter June -17.95 % - - -
I Quarter March 56 % - - -
FY (Year on Year)   - - - -




Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #175
Healthcare Sector #465
Overall #3049

Revenue Y/Y Growth Statistics
High Average Low
114.72 % 36.37 % -41.98 %
(Jun 30 2023)   (Sep 30 2023)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #175
Healthcare Sector #465
Overall #3049
Revenue Y/Y Growth Statistics
High Average Low
114.72 % 36.37 % -41.98 %
(Jun 30 2023)   (Sep 30 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Comera Life Sciences Holdings Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
60.11 % 9.37 % -56.73 %
(Sep 30 2022)  


CMRA's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Comera Life Sciences Holdings Inc disclosed fall in Revenue from the second quarter by -57.4% to $ 0.14 millions, from $ 0.32 millions achived in the previous quarter.

Even periodic circumstance which commonly elevate III. Quarter 2023 Revenue, that plainly was not enough to salvage CMRA's III. Quarter 2023 outcome, Sofia R. Adams, a business contributor allocated in Seattle wrote.

Within Major Pharmaceutical Preparations industry 214 other companies have achieved higher Revenue quarter on quarter growth. While Comera Life Sciences Holdings Inc 's Revenue growth quarter on quarter, overall rank is 3392.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #215
Healthcare Sector #553
Overall #3392
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #215
Healthcare Sector #553
Overall #3392
Revenue Q/Q Growth Statistics
High Average Low
60.11 % 9.37 % -56.73 %
(Sep 30 2022)  


CMRA's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Comera Life Sciences Holdings Inc disclosed fall in Revenue from the second quarter by -57.4% to $ 0.14 millions, from $ 0.32 millions declared in the previous quarter.

Albeit seasonal circumstance which usually fuel III. Quarter 2023 Revenue, this simply could not be sufficient to salvage Major Pharmaceutical Preparations's company outcome, Sofia R. Adams, a business contributor allocated in Seattle wrote.

Within Major Pharmaceutical Preparations industry 214 other companies have achieved higher Revenue quarter on quarter growth. While Comera Life Sciences Holdings Inc 's Revenue growth quarter on quarter, overall rank is 3392.


Comera Life Sciences Holdings Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 1.10 $ 1.19 $ 1.03 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) -8.26 % 16.41 % - - -
Seq. Revenue Growth (TTM) Overall Ranking # 1007 # 1169 # 0 # 0 # 0




Cumulative Revenue growth Comment


Comera Life Sciences Holdings Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 98
Sector # 228
S&P 500 # 1007
Cumulative Revenue growth Comment


Comera Life Sciences Holdings Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 98
Sector # 228
S&P 500 # 1007




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CMRA's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CMRA's Competitors
Revenue Growth for Comera Life Sciences Holdings Inc 's Suppliers
Revenue Growth for CMRA's Customers

You may also want to know
CMRA's Annual Growth Rates CMRA's Profitability Ratios CMRA's Asset Turnover Ratio CMRA's Dividend Growth
CMRA's Roe CMRA's Valuation Ratios CMRA's Financial Strength Ratios CMRA's Dividend Payout Ratio
CMRA's Roa CMRA's Inventory Turnover Ratio CMRA's Growth Rates CMRA's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Procyon Corporation-0.22%$ -0.221 millions
Amedisys Inc-0.31%$ -0.314 millions
Karyopharm Therapeutics Inc -0.38%$ -0.376 millions
Establishment Labs Holdings Inc -0.50%$ -0.505 millions
Opko Health Inc -0.64%$ -0.639 millions
Integra Lifesciences Holdings Corp-0.72%$ -0.719 millions
Healthcare Services Group Inc -0.75%$ -0.748 millions
Phibro Animal Health Corporation-0.77%$ -0.772 millions
Bionexus Gene Lab Corp -0.83%$ -0.831 millions
Bellicum Pharmaceuticals Inc -0.89%$ -0.890 millions
Prestige Consumer Healthcare Inc -1.12%$ -1.125 millions
Sharecare Inc -1.13%$ -1.127 millions
Lifevantage Corp-1.14%$ -1.140 millions
Organon and Co -1.17%$ -1.171 millions
Optinose Inc -1.27%$ -1.270 millions
Baxter International Inc -1.72%$ -1.723 millions
Puma Biotechnology Inc -1.73%$ -1.727 millions
Blueprint Medicines Corporation-1.76%$ -1.763 millions
Standard Biotools Inc -1.92%$ -1.918 millions
Pacira Biosciences inc -2.11%$ -2.114 millions
Bristol myers Squibb Company-2.25%$ -2.246 millions
Aurinia Pharmaceuticals Inc -2.27%$ -2.266 millions
Abbott Laboratories-2.56%$ -2.565 millions
Enhabit Inc -2.79%$ -2.785 millions
Novocure Limited-2.81%$ -2.807 millions
Uniqure N v -2.90%$ -2.899 millions
Vaso Corporation-2.92%$ -2.925 millions
Scientific Industries Inc -3.16%$ -3.165 millions
Akumin Inc -3.21%$ -3.205 millions
Syros Pharmaceuticals Inc -3.32%$ -3.315 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com